• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 5. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde (CAS No. 128843-61-8)

4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde (CAS No. 128843-61-8) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various applications, particularly in the development of novel therapeutic agents.

The molecular structure of 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde consists of a pyrrole ring substituted with a 4-fluorobenzoyl group and a methyl group. The presence of the fluorine atom in the benzoyl moiety imparts unique electronic and steric properties to the molecule, which can influence its biological activity and reactivity. These properties make it an attractive candidate for drug design and synthesis.

Recent studies have highlighted the importance of fluorinated compounds in medicinal chemistry due to their ability to enhance the pharmacological properties of drugs. For instance, the introduction of fluorine atoms can improve the metabolic stability, lipophilicity, and binding affinity of molecules, thereby enhancing their therapeutic efficacy. In this context, 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde has been investigated for its potential as a lead compound in the development of new drugs targeting various diseases.

One notable area of research involving 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde is its application in cancer therapy. Studies have shown that this compound exhibits potent antiproliferative activity against several cancer cell lines. The mechanism of action is believed to involve the inhibition of key enzymes involved in cell proliferation and survival pathways. Additionally, the compound's ability to induce apoptosis in cancer cells has been well-documented, making it a promising candidate for further investigation.

Beyond cancer therapy, 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde has also shown potential in other therapeutic areas. For example, it has been evaluated for its anti-inflammatory properties and has demonstrated significant activity in reducing inflammation in preclinical models. This makes it a potential candidate for the treatment of inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

The synthesis of 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde involves a series of well-established chemical reactions. The key steps typically include the formation of the pyrrole ring, followed by substitution with the 4-fluorobenzoyl group and methylation. Recent advancements in synthetic methodologies have led to more efficient and scalable routes for the production of this compound, making it more accessible for large-scale research and development.

In addition to its therapeutic potential, 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde has also been studied for its use as a building block in organic synthesis. Its unique structural features make it a valuable intermediate for the preparation of more complex molecules with diverse biological activities. This versatility has led to its widespread use in academic and industrial laboratories.

The safety profile of 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde is an important consideration in its development as a therapeutic agent. Preclinical studies have shown that it exhibits low toxicity at effective concentrations, which is a favorable attribute for drug candidates. However, further research is needed to fully understand its safety profile and potential side effects.

In conclusion, 4-(4-Fluorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde (CAS No. 128843-61-8) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique structural features, coupled with its biological activities, make it an attractive candidate for further investigation and development as a novel therapeutic agent. Ongoing research continues to uncover new insights into its properties and potential uses, solidifying its importance in the field.

• 154581-89-2(4-Acetyl-1,2-dimethylpyrrole)
• 338978-14-6(4-(3-Chlorobenzoyl)-1-methyl-1H-pyrrole-2-carbaldehyde)
• 62128-39-6(Methanone, (1,5-dimethyl-1H-pyrrol-3-yl)(4-methylphenyl)-)
• 108213-07-6(1,1'-(1-methyl-1H-pyrrole-2,4-diyl)bis-Ethanone)
• 128843-58-3(4-Benzoyl-1-methyl-1H-pyrrole-2-carbaldehyde)
• 117378-81-1(1-Methyl-4-(4-methylphenyl)carbonyl-1H-pyrrole-2-carbaldehyde)
• 1144047-29-9(4-(2-fluorobenzoyl)-1H-Pyrrole-2-carboxaldehyde)
• 501125-34-4(1H-Pyrrole-2-carboxaldehyde, 1-methyl-4-(phenylacetyl)-)
• 501125-36-6(1H-Pyrrole-2-carboxaldehyde, 4-benzoyl-1-phenyl-)
• 75866-91-0(4-Acetyl-1-methyl-1H-pyrrole-2-carbaldehyde)